"This intervention therapy addresses a market which has been estimated to be $85 billion in size and Dr. Marcus’ approach can help potentially millions of people experience relief from chronic pain for the first time," said Joe Valenzano, the CEO of EPGL. This marks a significant expanded direction for EPGL."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.